Clinical efficacy of pulsed radiofrequency combined with lidocaine intravenous infusion in the treatment of subacute herpes zoster neuralgia

Clinical efficacy of pulsed radiofrequency combined with lidocaine intravenous infusion in the treatment

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100051192

Enrollment

Unknown

Registered

2021-09-15

Start date

2021-09-13

Completion date

Unknown

Last updated

2022-05-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

herpes zoster neuralgia

Interventions

Group A:normal sodium

Group B:lidocaine

Eligibility

Sex/Gender

Male

Age

50 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with subacute herpes zoster neuralgia; 2. Patients without serious organ dysfunction such as heart, lung and kidney; 3. 1= 4 points; 5. Aged 50 to 75 years; understand the experimental interventions and volunteer to participate in the group study.

Exclusion criteria

Exclusion criteria: 1. Abnormal coagulation function; 2. Local or systemic infection; 3. Combined with immune and endocrine system diseases; 4. Cancer patients.

Design outcomes

Primary

Measure	Time frame
pain score;	—

Secondary

Measure	Time frame
Pittsburgh sleep quality index, PSQI;	—

Countries

China

Contacts

Public ContactHe Chunjing

Guizhou Provincial People's Hospital

hcj777330@163.com+86 13608538330

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026